NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lmito Therapeutics

Lmito Therapeutics

Private
South KoreaHealthcare & Life Scienceshttps://www.lmito.com/

Last Round

Series A

Aug 31, 2020

Total Funding Raised

$5.89M

Company Overview

Lmito Therapeutics is a clinical-stage pharmaceutical company that develops novel therapies for autoinflammatory, autoimmune, and fibrotic diseases through metabolic reprogramming.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule drugsmetabolic reprogrammingbiotechdrug discoveryimmunometabolismfibrosis treatmentneuroinflammationdrug pipelinebiopharmaclinical-stage biotechfully integrated pharmaceutical networkFIPNetdrug licensingprecision medicinetherapeutic platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lmito Therapeutics Comparables

Compare Lmito Therapeutics with similar companies based on industry and business-model similarity.

Lmito Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sitryx
85%
Capacity Bio
78%
Innovo Therapeutics
78%

Lmito Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 31, 2020

Key People

Founding team and executive leadership

Wheeseong Lee

CEO Founder

Founding Team

Eunju Lee

Chief Operating Officer

Executive Team

Lmito Therapeutics Investors

Notable investors and investment history

Lmito Therapeutics investors
InvestorRounds
Dt& InvestmentSeries A
Yuanta InvestmentSeries A
Kiwoom InvestmentSeries A
Stonebridge VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 98% MoM, reaching 3.6K.

  • Jan 25, 2025

    Monthly visitors grew 114% MoM, from 514 to 1.1K.

Lmito Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lmito Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lmito Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range7
Year Founded2019
Last FundingAug 31, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.